A detailed history of Nisa Investment Advisors, LLC transactions in Aclaris Therapeutics, Inc. stock. As of the latest transaction made, Nisa Investment Advisors, LLC holds 527 shares of ACRS stock, worth $616. This represents 0.0% of its overall portfolio holdings.

Number of Shares
527
Holding current value
$616
% of portfolio
0.0%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 19, 2024

BUY
$1.01 - $1.36 $532 - $716
527 New
527 $0
Q3 2023

Nov 02, 2023

SELL
$6.56 - $10.95 $14,313 - $23,892
-2,182 Reduced 67.16%
1,067 $7,000
Q2 2023

Aug 11, 2023

BUY
$7.89 - $10.64 $22,107 - $29,813
2,802 Added 626.85%
3,249 $33,000
Q1 2023

May 02, 2023

SELL
$7.07 - $17.95 $10,138 - $25,740
-1,434 Reduced 76.24%
447 $4,000
Q3 2022

Nov 07, 2022

BUY
$13.07 - $18.22 $692 - $965
53 Added 2.9%
1,881 $29,000
Q2 2022

Aug 03, 2022

BUY
$10.16 - $17.08 $18,572 - $31,222
1,828 New
1,828 $26,000

Others Institutions Holding ACRS

About Aclaris Therapeutics, Inc.


  • Ticker ACRS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 66,671,800
  • Market Cap $78M
  • Description
  • Aclaris Therapeutics, Inc. operates a clinical-stage biopharmaceutical company, develops novel drug candidates for immune-inflammatory diseases in the United States. It operates through two segments: Therapeutics and Contract Research. The Therapeutics segment is involved in identifying and developing innovative therapies to address significant ...
More about ACRS
Track This Portfolio

Track Nisa Investment Advisors, LLC Portfolio

Follow Nisa Investment Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nisa Investment Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nisa Investment Advisors, LLC with notifications on news.